ANGELA
PEÑALVA MAQUEDA
Investigadora en el periodo 1989-2022
FELIPE
CASANUEVA FREIJO
Investigador en el periodo 1992-2024
Publicaciones en las que colabora con FELIPE CASANUEVA FREIJO (22)
2002
-
Presence of bovine leptin in edible commercial milk and infant formula
Journal of Endocrinological Investigation, Vol. 25, Núm. 8, pp. 670-674
2001
-
Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients
Clinical Endocrinology, Vol. 54, Núm. 4, pp. 509-513
-
Involvement of nitric oxide in the regulation of growth hormone secretion in dogs
Neuroendocrinology, Vol. 74, Núm. 4, pp. 213-219
-
Physiology and possible pathology of growth hormone secretagogues
Journal of Pediatric Endocrinology and Metabolism, Vol. 14, Núm. SUPPL. 5, pp. 1207-1212
1998
-
Acute changes in free-fatty acids (FFA) do not alter serum leptin levels
Journal of Endocrinological Investigation, Vol. 21, Núm. 8, pp. 526-530
-
Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism
Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 12, pp. 4350-4354
-
La administracion por via oral de dosis bajas de growth hormone releasing hexapeptide-6-mas piridostigmina es un estimulo adecuado de la secrecion de GH
Endocrinologia, Vol. 45, Núm. 10, pp. 341-344
1996
-
Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli
Journal of Clinical Endocrinology and Metabolism, Vol. 81, Núm. 3, pp. 909-913
-
Growth hormone releasing hexapeptide-6 (GHRP-6) in test in the diagnosis of GH-deficiency
Journal of Pediatric Endocrinology and Metabolism
-
Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression
Journal of Clinical Endocrinology and Metabolism, Vol. 81, Núm. 3, pp. 914-918
1995
-
Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection
Journal of Clinical Endocrinology and Metabolism, Vol. 80, Núm. 11, pp. 3180-3184
-
Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects
Metabolism, Vol. 44, Núm. 6, pp. 745-748
-
Plasma growth hormone response to growth hormone‐releasing hexapeptide (GH‐RP‐6) in children with short stature
Acta Pædiatrica, Vol. 84, Núm. 8, pp. 904-908
1994
-
CONTROL PEPTIDERGICO DE LA SECRECION DE HORMONA DE CRECIMIENTO
Endocrinologia, Vol. 41, Núm. SUPPL. 2, pp. 9-16
1993
-
Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man
Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 1, pp. 168-171
-
Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6
Clinical Endocrinology, Vol. 38, Núm. 1, pp. 87-91
-
Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity
Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 4, pp. 819-823
1990
-
Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man
Neuroendocrinology, Vol. 51, Núm. 1, pp. 51-58
-
Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects
Journal of Clinical Endocrinology and Metabolism, Vol. 70, Núm. 2, pp. 324-327
-
ROLE OF CHOLINERGIC MUSCARINIC PATHWAYS ON THE FREE FATTY ACID INHIBITION OF GH RESPONSES TO GHRH IN NORMAL MEN
Clinical Endocrinology, Vol. 33, Núm. 2, pp. 171-176